Xenothera
Francoise S. is an experienced medical professional currently serving as the Chief Medical Officer at XENOTHERA since April 2021. Prior roles include Médecin aire thérapeutique oncologie at Amgen from June 2012 to April 2021, Medical Manager Haematology at Roche between April 2011 and May 2012, and Medical Science Liaison at Janssen Cilag from 2004 to 2011. Francoise S. began a career in the medical field as a Medical Affairs professional at Schering-Plough from 2001 to 2004, and as an MSL at Wyeth from 1999 to 2001.
This person is not in any teams
Xenothera
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases.Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovatespassive immunotherapy by marketing a new generation of hyperimmune polyclonal sera.Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.